Ship Healthcare Holdings, Inc. revised consolidated earnings guidance for the Fiscal Year Ending March 31, 2024. For the year, the company now expects net sales of JPY 600,000 million, Operating profit of JPY 23,500 million, profit attributable to owners of the parent of JPY 12,500 million and net income per share of JPY 132.49 against previous guidance of net sales of JPY 600,000 million, Operating profit of JPY 24,000 million, profit attributable to owners of the parent of JPY 13,500 million and net income per share of JPY 143.08.
Ship Healthcare Holdings, Inc.
Equities
3360
JP3274150006
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,314 JPY | +2.03% | +7.50% | -3.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.90% | 1.39B | |
-3.41% | 9.4B | |
+30.20% | 1.92B | |
-7.38% | 1.18B | |
-18.42% | 857M | |
+0.48% | 470M | |
+3.62% | 437M | |
-49.68% | 360M | |
-24.72% | 333M | |
-2.42% | 212M |
- Stock Market
- Equities
- 3360 Stock
- News Ship Healthcare Holdings, Inc.
- Ship Healthcare Holdings, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024